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Summary The effect of temperature on the cytotoxicity of melphalan in a pleiotropic drug-resistant mutant
CHO cell line (CHR C5) and in its drug-sensitive parent (Aux BI) was studied in vitro using a clonogenic
assay. The cytotoxicity of melphalan was significantly enhanced at elevated but non-lethal temperatures
(39-41 'C) and hyperthermia potentiated the effect ofmelphalan in the lethal temperature range (43-44 'C) in
both cell lines. The effect of temperature on membrane permeability to melphalan was studied to determine
whether the increase in cytotoxicity was associated with increased intracellular drug levels. The uptake of
'4C-labelled melphalan during 5 min increased with increasing temperature. Drug efflux, however, also
increased at elevated temperatures. Intracellular drug levels at equilibrium were increased at elevated tempera-
tures but the magnitude of this effect was small in comparison with the much larger increases in cytotoxicity.
The failure of chemotherapy to eradicate tumours which
initially respond to treatment may be due to the selection of
drug-resistant clones of tumour cells (Goldie & Coldman,
1979). It has been shown that the acquisition of resistance to
one cytotoxic drug may confer cross resistance to several
other chemotherapeutic agents and that this pleiotropic drug
resistance is frequently associated with increased expression
of a 170,000 dalton glycoprotein (p-glycoprotein) (Center,
1983; Louie et al., 1986; Riordan & Ling, 1979). There is
good evidence that p-glycoprotein is part of a cellular export
system which increases drug efflux by an energy dependent
mechanism (Center, 1983; Dano, 1973; Gerlach et al., 1986;
Inaba et al., 1979; Skovsgaard, 1978), although reduction in
intracellular drug levels alone is insufficient to account for
the level of resistance observed in some systems (Bates et al.,
1985a). It has previously been shown that influx of several
chemotherapeutic agents is increased at elevated temperatures
(Bates & Mackillop, 1986; Hahn, 1979; Nagaoka et al., 1986)
and we have therefore explored the possibility that hyperther-
mia might be capable of overcoming the type of pleiotropic
drug resistance which is associated with increased drug efflux.
The combination of hyperthermia with certain chemothe-
rapeutic agents has exhibited potentiation of effect in experi-
mental systems (Barlogie et al., 1980; Bates et al., 1987b;
Bates & Mackillop, 1986; Hahn, 1979; Herman et al., 1982;
Nagaoka et al., 1986). Regional hyperthermia, therefore, has
the potential to increase the cytotoxic effects of a systemically
administered agent within a defined target region and may
thus be ofclinical value. Thermo-chemotherapy has not been
extensively tested in human tumours but for some time mel-
phalan has been used with hyperthermia in the treatment of
human melanoma by a limb perfusion (Rege et al., 1983;
Stehlin, 1980; Storm et al., 1982). Studies of the interaction
between hyperthermia and melphalan at the cellular level
have, until now, been limited (Bates et al., 1987b). We have
therefore studied the effect of elevated temperatures on mel-
phalan transport and cytotoxicity in a pleiotropic drug-resis-
tant CHO cell line which expresses p-glycoprotein, and in the
drug-sensitive parent cell line.
Materials and methods
Tissue culture
The pleiotropic drug resistant cell line CHI C5 used for this
study was selected for resistance to colchicine from the
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AuxBl drug-sensitive parent CHO cell line (Ling & Thomp-
son, 1974). The resistance factor to colchicine is 300. The cell
line is also resistant to other chemotherapeutic agents and a
resistance factor to melphalan of 15 has been reported (Elliot
& Ling, 1981). The AuxBl and CHR C5 cell lines were grown
in monolayer in 75 cm2 plastic tissue culture flasks (Falcon,
Becton-Dickinson Canada Inc., Mississauga, Ontario) at
37°C under 5% CO2 in minimum essential medium Alpha
(MEM Alpha) (Gibco Canada, Burlington, Ontario), supp-
lemented with 10% fetal bovine serum (FBS) (Gibco
Canada) and 1% penicillin (50 units ml-')-streptomycin
(50fgml-') (Flow Laboratories, Mississauga, Ontario).
Studies were carried out using cells grown to confluence and
incubated for 24 h at 37°C with fresh culture medium. Cells
were harvested with sodium citrate (0.015 M) in phosphate-
buffered saline (PBS) (0.14 M NaCl, 0.01M sodium phos-
phate), washed by centrifugation and resuspended in PBS
containing 1% bovine serum albumin (BSA) and 10mM
glucose for experimental studies.
Cytotoxicity experiments
Melphalan (Wellcome Medical Division, Burroughs Well-
come Inc., Kirkland, Ontario) was freshly prepared before
each experiment and kept on ice at all times. It was dissolved
in a minimum volume of ethanol (95%): HCI (2% w/v)
solution and then diluted to the appropriate concentration in
culture medium in screw-topped polystyrene tubes. The final
concentrations of ethanol and HCI did not exceed 0.005%
and 0.001% respectively, and did not affect the pH of the
solution or contribute to cytotoxicity, as previously reported
by others (Bosanquet, 1985).
Aliquots of 0.1 ml of cells (106ml') were added to 0.9 ml
of melphalan solution (prewarmed for 3 min at the incuba-
tion temperature). The tubes were incubated in a temperature
controlled waterbath (Haake D3, Saddle River Road, Saddle
Brook, New Jersey) at temperatures ranging from 37°C to
45°C. Under these conditions 1 ml of aqueous solution reach-
ed a temperature within 0.1C of the waterbath temperature
within 3 min. Tubes were removed from the waterbath after
a 20 min incubation and then centrifuged (2 min, 1,000g),
washed once, and the cells were resuspended in culture
medium. The cells were carefully mixed before diluting to the
appropriate concentration and plating in tissue culture-coat-
ed Petri dishes. The Petri dishes were incubated at 37°C in an
atmosphere of 5% CO2 for 10 days. The plates were washed
with PBS, fixed with 95% ethanol and stained with methy-
lene blue before counting macroscopic colonies (> 50 cells).
Control plating efficiencies were greater than 60%. Percen-
tage survival was expressed as the mean number of colonies
obtained relative to the mean number of colonies obtained in
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the control. Two hundred cells per plate were seeded in the
control, but where levels of cell survival were uncertain, cells
were plated at more than one density to ensure that count-
able colonies would be obtained, and the results were correct-
ed accordingly.
Calculation ofthermal enhancement ratios (TERs)
The TER is the ratio of drug doses with and without the
application of heat required to produce a given level of
biological damage. The TERs were calculated from the con-
centration of melphalan required to produce a level of 50%
cell survival, obtained from dose-response curves at each
temperature. The dose-response curves were corrected to
remove the cytotoxicity produced by the heat alone. For a
given elevated temperature, the TER was expressed as the
ratio of the melphalan concentration required to produce
50% cell survival at 37°C relative to the melphalan concen-
tration required to produce 50% cell survival at the elevated
temperature.
Measurement ofmelphalan uptake
"4C-labelled melphalan (specific activity 43.8 ,uCi mg-') was a
gift from SRI International, Ravenswood Ave., Menlo Park,
California. Melphalan was dissolved in a minimum volume
of ethanol (95%): HCI (2% w/v) solution and then diluted to
the appropriate concentration in PBS containing 1% BSA
and 10mM glucose. The final pH of the solution was 7.3.
Freshly harvested CHO cells were resuspended at 107 cells
ml-' in PBS containing 1% BSA and 10 mM glucose at room
temperature. 100 ly aliquots were placed in glass tubes and
preheated for 2 min in a circulating waterbath to allow them
to reach the incubation temperature before the addition of
melphalan. Final melphalan concentrations varied from 0.5
to 30lag ml-'. The temperature of the cells was monitored
with a 24 gauge hypodermic thermistor temperature probe
(Yellow Springs Instrument Co., Inc., Yellow Springs, Ohio)
and was found to reach the temperature of the waterbath
within 30 s. At time zero, 100 .ld aliquots of freshly prepared
melphalan solution, previously equilibrated at the incubation
temperature for 3 min, were added to the cells and the
suspension was mixed and incubated for the required time.
To stop uptake, 4 ml of ice-cold PBS-BSA buffer were added
and the cells were centrifuged (1 min, 1,000g) and washed 3
times with ice-cold PBS-BSA. The final dry pellet of cells was
solubilised with 1% SDS and the liquid scintillation cocktail
Scinti Verse II (Fisher Scientific Co., Devonshire Rd., Mon-
treal, Quebec) was added. The radioactivity was determined
using an LKB model 1218 Rackbeta liquid scintillation
counter equipped with a dpm calculation program (Fisher
Scientific Co.). We have previously measured no change in
cell volume after 60 min at temperatures ranging fom 37°C to
45°C (Bates & Mackillop, 1986), therefore melphalan uptake
was not normalised with respect to cell volume at elevated
temperatures.
Measurement ofmelphalan effiux
Freshly harvested CHO cells (107 ml-') were pre-loaded with
melphalan (5 ygml-') for 15 min at 37°C in PBS containing
1% BSA and 10 mM glucose at pH 7.3. The cells were centri-
fuged (2 min, 1,000g) and washed three times with ice-cold
PBS-BSA. For efflux measurements the cells were resuspend-
ed in ice-cold melphalan-free PBS-BSA-glucose and aliquoted
into 100 pl lots in glass tubes. A volume of 0.3 ml of PBS-
BSA-glucose (prewarmed at the incubation temperature) was
added and the cells incubated for varying times at temper-
atures from 37°C to 45°C. To stop efflux the cell suspensions
were centrifuged after addition of 3.4 ml ice-cold PBS-BSA,
and the radioactivity was determined in the cell pellet. The
zero time point represents the melphalan content in the cells
prior to efflux and each time point is expressed as a percent-
age of this point.
Results
Figure 1 shows dose-response curves for melphalan cytotox-
icity in drug-sensitive (AuxBl) and drug-resistant (CHR C5)
CHO cells. The resistant cells were 14-fold more resistant to
melphalan with respect to the drug-sensitive cells, based on
the drug concentration required to reduce the percentage cell
survival to 10%.
Figure 2a shows the survival of the parent drug-sensitive
cell line as a function of temperature during a 20 minute
exposure to several different concentrations of melphalan
(0.025-0.2fig ml-') compared to controls which were incu-
bated at the same temperatures in the absence of melphalan.
Figure 2b shows similar data for the drug-resistant cell line
(CHR C5) for melphalan concentrations ranging from 0.1 to
1.5,ug ml'. A comparison of the curves representing cell
survival at elevated temperatures in the absence of melphalan
shows that the thermal response of the two cell lines is
similar. In both cell lines we observed that the cytotoxicity of
melphalan was enhanced in the elevated but non-lethal tem-
perature range between 39°C and 42°C and at the lethal
temperatures of 43°C and 44°C. The data shown in Figure 2a
and b were corrected for heat-induced cytotoxicity and re-
plotted to give dose-response curves at each temperature
(graphs not shown). Subsequently, thermal enhancement ratios
(TER) were calculated at each temperature for both the
drug-sensitive and drug-resistant cell lines (Figure 3). The
TERs shown in Figure 3 clearly illustrate the enhancement of
melphalan cytotoxicity in both cell lines at elevated temper-
atures. The enhancement was most pronounced from 42°C to
44°C. The TERs at 45°C were lower and this is probably due
to the large amount of killing induced by the heat alone. The
data show that the enhancement was greater in the drug-
resistant cells compared to the sensitive cells, and that the
difference between the cell lines was more marked at temper-
atures from 41°C to 44°C.
Figure 4 shows the uptake of '4C-labelled melphalan into
the two cell lines as a function of time and environmental
temperature. The plateau levels of melphalan were lower in
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Figure 1 Dose-response curves for melphalan cytotoxicity in
drug-sensitive (@) and drug-resistant (0) CHO cells. Cell sus-
pensions containing IO0 CHO cells and melphalan (0-3jug ml-')
in 1 ml of PBS-i % BSA-l0 mM glucose were incubated for 20
min at 37°C. Means are given for 3 estimations. s.d.s represent
inter-experimental error and are based on 3 independent experi-
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Figure 2 Melphalan cytotoxicity versus temperature in (a) drug-
sensitive and (b) drug-resistant CHO cells. Cell suspensions con-
taining 105 CHO cells and (a): 0 (-), 0.025 (*), 0.05 (0), 0.1
(0) or 0.2 (A) pgml-' melphalan or (b): 0 (U), 0.1 (0), 0.2
(A), 0.5 (A), 0.75 (0), 1.0 (0) or 1.5 (U) lAgml-I melphalan in
1 ml of PBS-I% BSA-l0 mM glucose were incubated for 20 min
at the temperatures shown. Means for % cell survival are given
for 3 estimations, and were reproducible in 7 independent
experiments. s.d.s are not shown to avoid overcrowding on the
graphs.
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Figure 3 The thermal enhancement ratio (TER) for drug-
sensitive (0) and drug-resistant (-) CHO cells. The TER is the
ratio of drug doses with and without the application of heat
required to produce a given level of biological damage. The
graph represents the concentration of drug required to prbduce a
level of 50% cell survival in 20 minutes, calculated from the data
shown in Figure 2.
the drug-resistant CHRC5 line. In both cell lines, plateau
levels of melphalan were similar between 40°C and 45°C and
all were a little higher than the plateau level observed at
37°C. Temperature appeared to have a greater influence on
intracellular levels of melphalan at earlier times and this is
better illustrated in Figure 5, which shows melphalan uptake
as a function of extracellular melphalan concentration during
a 5 minute incubation. Intracellular levels of melphalan were
lower in the CHR C5 cell line. In both cell lines, however,
intracellular drug concentrations were influenced by tempera-
ture and in the CHR C5 line, for example, uptake at 43C
was approximately double that at 37°C. We were unable to
study uptake over shorter time intervals because of limita-
tions imposed by our methodology. Intracellular drug levels
at 5 minutes certainly cannot be equated with initial rates of
drug influx and may be already highly dependent on rates of
efflux.
Time courses of efflux of melphalan from drug-sensitive
and drug-resistant cells are shown as a function of temper-
ature in Figure 6. The cells were preloaded with melphalan
(5figml ), washed and resuspended in medium which was
free of extracellular melphalan at time zero. During the
course of the experiment, melphalan slowly accumulates in
the extracellular fluid but we have calculated that for efflux
time points studied here, extracellular melphalan concentra-
tions were very low and at no point exceeded 1% of the
intracellular drug concentration. Initial rates of efflux of
melphalan (up to 20 min) in the resistant cell line exceeded
those observed in the drug-sensitive cell line at the temper-
atures 37°C, 40°C and 43°C. No difference was detected
between the two cell lines at 45°C for times up to 20 minutes.
Efflux in the drug-resistant cell line is clearly biphasic and
following a rapid initial efflux phase intracellular levels
appear to plateau by 30 minutes. There were no significant
changes in initial rates of efflux as a function of temperature
in the resistant cell line. Initial efflux rates (up to 20 min) for
the drug-sensitive line increased with temperature up to 43°C.
In the drug-sensitive cell line, initial rates of efflux were less
rapid and although there may be a tendency for the efflux
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the time frame ofthis experiment. Prolongation ofthe experi-
ment beyond 1 hour is probably not useful because at ele-
vated temperatures most of the cells are dead by this time. At
45°C the data beyond the 20 minute point should be treated
with caution since by this point more than 99% of the cells
are already reproductively dead (Bates et al., 1985b). There
was no clear difference between the 60 min intracellular drug
concentrations for the two cell lines at temperatures from
37TC to 43C. At 45C, the intracellular drug concentration
was higher in the drug-resistant cells. It should be pointed
out, however, that the efflux data were obtained in the
absence of extracellular drug and thus under conditions
where drug influx is negligible. However, in the presence of
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Figure 4 Time courses for melphalan uptake in (a) drug-
sensitive and (b) drug-resistant CHO cells at elevated
temperatures. Uptake of '4C-labelled melphalan was measured for
varying times up to 50 min at 37°C (O), 41C (V), 43°C (0) and
45°C (A) in solutions containing 106 cells and melphalan
(5 jig ml- ) in 0.2 ml PBS-BSA-glucose. Means and s.d. are given
for 3 estimations,-and are representative of data obtained from 3
experiments.
Figure 5 Melphalan uptake as a function of external drug con-
centration in (a) drug-sensitive and (b) drug-resistant CHO cells
at elevated temperatures. Melphalan uptake- was measured for
5 min at 37°C (A), 40°C (0), 43°C (0), and 45°C (A), in
solutions containing 106 cells and melphalan (0.5 -301g ml-') in
0.2 ml PBS-BSA-glucose. Means and s.d. are given for 3 estima-
tions, and are representative of data obtained from 3
experiments. The majority of s.d.s lie within the symbols.
extracellular drug, whereby both the processes of influx and
efflux are occurring, the intracellular drug concentration at
equilibrium was higher in the drug-sensitive cells relative to
the resistant cells (Figure 4).
Discussion
We have demonstrated a 14-fold increase in resistance to
melphalan of the CHR C5 cell line relative to the drug-
sensitive parent cell line, when drug treatments were carried
out in PBS-BSA-glucose medium. This finding is in close
agreement with other studies performed by Elliott and Ling
(1981) using PBS medium. However, a comparison of the
two studies showed that less cytotoxicity occurred in our
study in which the medium contained protein. This could be
explained either by increased sensitivity of the cells to the
drug when incubated in the absence of protein, or decreased
free drug concentration in the solution due to protein bind-
ing.
Melphalan is taken up by two separate amino acid trans-
port systems (Goldenberg & Begleiter, 1980; Goldenberg et
al., 1979). Previous studies have reported no significant
difference in the rate of drug influx (2min) between the
drug-sensitive and drug-resistant CHO cell lines used in this
study, despite a higher Vmax in the drug-sensitive cells
(Begleiter et al., 1983). These findings were based on kinetic
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Figure 6 Semilog plots of efflux versus time in drug-sensitive (0) and drug-resistant (A) CHO cells at elevated temperatures. Cell
suspensions containing 106 cells preloaded with melphalan were allowed to efflux in a volume of 0.4ml of melphalan-free
PBS-BSA-glucose at (a) 37°C, (b) 40C, (c) 43°C, and (d) 45°C. Means and s.d. are given for 3 estimations, and are representative
of data obtained from 3 experiments.
parameters determined by the Neal analysis (Neal, 1972) for
interaction of a two-component transport system. We have
previously reported, however, that there are very large errors
on kinetic parameters determined using this analysis (Bates et
al., 1987a). Our data in this study suggest that there is a
difference between melphalan uptake between the two cell
lines at 5 min and at equilibrium. In agreement with previous
findings (Begleiter et al., 1983), there was an increased rate of
efflux in the drug-resistant line relative to the sensitive line.
As yet, the mechanism for melphalan efflux is unknown.
There are two possible explanations for the biphasic appear-
ance to the efflux curves. The first is that there are two
distinct efflux mechanisms. The second is that not all of the
melphalan ultimately escapes from the cell and that some
remains firmly sequestered in the cell. This would be
exhibited as an initial exponential decrease in melphalan
concentration which slows down and approaches the equilib-
rium concentration asymptotically, thus giving a biphasic
appearance to the curves.
It has been shown that higher intracellular levels of mel-
phalan are achieved at elevated temperatures in both drug
sensitive CHO cells and in a p-glycoprotein producing resis-
tant mutant. Melphalan efflux increased with temperature up
to 43°C in the drug-sensitive cells, but we were unable to
detect any change in rates of drug efflux with temperature in
the resistant cells over the range studied. The effects of
temperatures on melphalan transport described here are very
similar to the previously described effects of heat on adri-
amycin transport (Bates & Mackillop, 1986; Nagaoka et al.,
1986). This is unexpected since adriamycin probably enters
cells by passive diffusion (Siegfried et al., 1985) whereas
melphalan is taken up by at least two separate amino acid
transport systems (Goldenberg & Begleiter, 1980; Goldenberg
et al., 1979). We have predicted that melphalan uptake would
decrease with increasing temperature as we moved away from
the usual operating temperature of the transport system but
increases in the rate of facilitated diffusion (LeCavalier &
Mackillop, 1985) and active transport (Bates & Mackillop,
1985) of other molecules have been previously demonstrated
in this temperature range.
Both in the drug-sensitive and drug-resistant cell lines, the
cytotoxicity ofmelphalan was enhanced at temperatures from
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39°C to 44°C. This is in part explained by the increase in
drug uptake but it appears improbable that the changes in
intracellular drug level are of sufficient magnitude to explain
the observed potentiation of effect. The increase in cytotox-
icity to be expected on the basis of increased drug uptake
cannot be precisely calculated since the cytotoxicity of mel-
phalan decays as a function of time and ambient temperature
(Bates et al., 1987b) and the intracellular levels of drug
measured here cannot, therefore, be equated with active drug
levels. It seems likely however, that other mechanisms are
also involved in producing the potentiation between hyper-
thermia and melphalan. For example, melphalan will react
faster with target molecules at an elevated temperature.
This study confirms that the pleiotropic drug resistant
mutant studied has a heat sensitivity similar to that of the
parent line (Bates & Mackillop, 1986) and in addition, it has
been demonstrated that potentiation of effect between hyper-
thermia and melphalan is observed in the resistant line as
well as the sensitive line.
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